HUE047735T2 - Egy biometrikus peptid és biológiailag lebomló szállító rendszer az angiogenesis- és lymphangiogenesis függõ betegségek kezelésében - Google Patents
Egy biometrikus peptid és biológiailag lebomló szállító rendszer az angiogenesis- és lymphangiogenesis függõ betegségek kezelésébenInfo
- Publication number
- HUE047735T2 HUE047735T2 HUE14807179A HUE14807179A HUE047735T2 HU E047735 T2 HUE047735 T2 HU E047735T2 HU E14807179 A HUE14807179 A HU E14807179A HU E14807179 A HUE14807179 A HU E14807179A HU E047735 T2 HUE047735 T2 HU E047735T2
- Authority
- HU
- Hungary
- Prior art keywords
- lymphangiogenesis
- angiogenesis
- biometric
- peptide
- treatment
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000035168 lymphangiogenesis Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Nanotechnology (AREA)
- Wood Science & Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832290P | 2013-06-07 | 2013-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047735T2 true HUE047735T2 (hu) | 2020-05-28 |
Family
ID=52008639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14807179A HUE047735T2 (hu) | 2013-06-07 | 2014-06-09 | Egy biometrikus peptid és biológiailag lebomló szállító rendszer az angiogenesis- és lymphangiogenesis függõ betegségek kezelésében |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US9802984B2 (https=) |
| EP (2) | EP3643318A1 (https=) |
| JP (2) | JP6470740B2 (https=) |
| CN (2) | CN105431162B (https=) |
| AU (1) | AU2014274703B2 (https=) |
| CA (1) | CA2914764C (https=) |
| DK (1) | DK3003343T3 (https=) |
| ES (1) | ES2774217T3 (https=) |
| HU (1) | HUE047735T2 (https=) |
| IL (1) | IL242760B (https=) |
| WO (1) | WO2014197892A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6470740B2 (ja) * | 2013-06-07 | 2019-02-13 | ザ ジョンズ ホプキンス ユニバーシティ | 血管新生およびリンパ管新生依存性疾患の処置のための生体模倣ペプチドおよび生分解性送達プラットフォーム |
| WO2016022947A1 (en) | 2014-08-07 | 2016-02-11 | The Johns Hopkins University | Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases |
| KR101748120B1 (ko) * | 2015-07-13 | 2017-06-16 | 서울대학교산학협력단 | 나노입자-유리체 기반 단백질 복합체를 유효성분으로 포함하는 혈관신생억제용 조성물 및 이의 용도 |
| CN108883150A (zh) | 2015-11-19 | 2018-11-23 | 阿斯克雷佩西治疗公司 | 具有抗血管生成、抗淋巴管生成以及消水肿性质的肽和纳米粒子制剂 |
| MX2019003895A (es) * | 2016-10-04 | 2019-10-07 | Asclepix Therapeutics Inc | Compuestos y metodos para activar la señalizacion tie2. |
| US20200179285A1 (en) * | 2017-05-08 | 2020-06-11 | The Johns Hopkins University | Biodegradable microparticles for sustained delivery of anti-angiogenic peptide |
| EP3661536A4 (en) * | 2017-08-03 | 2021-07-21 | Asclepix Therapeutics, Inc. | PROCESS FOR IDENTIFICATION AND MANUFACTURING OF PHARMACEUTICAL INGREDIENTS FOR ACTIVATING A TIE2 RECEPTOR |
| WO2019075056A1 (en) | 2017-10-10 | 2019-04-18 | The Johns Hopkins University | BIODEGRADABLE BIOMIMETIC PARTICLES |
| US11697804B2 (en) | 2018-10-01 | 2023-07-11 | The Johns Hopkins University | Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy |
| US12280157B2 (en) * | 2019-02-06 | 2025-04-22 | The University Of North Carolina At Chapel Hill | Compositions and methods for inhibiting post-surgical adhesions |
| CN113710264A (zh) * | 2019-03-26 | 2021-11-26 | 阿斯克雷佩西治疗公司 | 用于治疗眼部疾病的组合物和方法 |
| WO2020210843A2 (en) | 2019-04-12 | 2020-10-15 | The Johns Hopkins University | Tolerogenic artificial antigen-presenting cells |
| CN113144213B (zh) * | 2021-03-23 | 2023-04-07 | 西安交通大学医学院第一附属医院 | 一种多级pH响应基因-药物共递送的纳米药物、制备方法及其应用 |
| WO2024044745A2 (en) * | 2022-08-26 | 2024-02-29 | Asclepix Therapeutics, Inc. | Formulations for intraocular delivery of peptides derived from type iv collagen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2015781A4 (en) * | 2005-09-12 | 2009-12-23 | Univ Johns Hopkins | COMPOSITIONS HAVING ANTIANGIOGENIC ACTIVITY AND USES THEREOF |
| EP2441846A3 (en) * | 2006-01-09 | 2012-07-25 | The Regents Of the University of California | Immunostimulatory combinations of TNFRSF, TLR, NLR, RHR, purinergic receptor, and cytokine receptor agoinsts for vaccines and tumor immunotherapy |
| ITMI20060625A1 (it) | 2006-03-31 | 2007-10-01 | Istituto Naz Per La Ricerca | Peptide antiangiogenico e suoi impieghi terapeutici |
| US20100111963A1 (en) * | 2006-11-10 | 2010-05-06 | Genentech, Inc. | Method for treating age-related macular degeneration |
| US8507434B2 (en) * | 2007-01-03 | 2013-08-13 | The Johns Hopkins University | Peptide modulators of angiogenesis and use thereof |
| WO2009135854A2 (en) * | 2008-05-06 | 2009-11-12 | Glaxo Group Limited | Encapsulation of biologically active agents |
| JP2011528566A (ja) * | 2008-07-21 | 2011-11-24 | コンプジェン リミティッド | アンジオポエチン由来ペプチド |
| WO2014066811A1 (en) | 2012-10-25 | 2014-05-01 | The Johns Hopkins University | Bioreducible poly (b-amino ester)s for sirna delivery |
| US9717694B2 (en) * | 2009-05-15 | 2017-08-01 | The Johns Hopkins University | Peptide/particle delivery systems |
| IN2012DN05099A (https=) * | 2009-12-16 | 2015-10-09 | Brigham & Womens Hospital | |
| US20120192339A1 (en) | 2010-07-28 | 2012-08-02 | Honeywell International Inc. | Flexible Body Armor Vest with Breast Plate |
| US20120270770A1 (en) * | 2010-08-03 | 2012-10-25 | Jesse Michael Jaynes | Anti-angiogenic peptides and their uses |
| EP2649095B1 (en) * | 2010-12-10 | 2021-10-06 | Aleksander S. Popel | Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases |
| JP5747312B2 (ja) | 2011-02-24 | 2015-07-15 | コニカミノルタ株式会社 | 活性光線硬化型インクジェットインク及び画像形成方法 |
| WO2014066898A1 (en) | 2012-10-26 | 2014-05-01 | The Johns Hopkins University | A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics |
| JP6470740B2 (ja) * | 2013-06-07 | 2019-02-13 | ザ ジョンズ ホプキンス ユニバーシティ | 血管新生およびリンパ管新生依存性疾患の処置のための生体模倣ペプチドおよび生分解性送達プラットフォーム |
-
2014
- 2014-06-09 JP JP2016518060A patent/JP6470740B2/ja active Active
- 2014-06-09 DK DK14807179.8T patent/DK3003343T3/da active
- 2014-06-09 EP EP19195992.3A patent/EP3643318A1/en active Pending
- 2014-06-09 US US14/896,521 patent/US9802984B2/en active Active
- 2014-06-09 CA CA2914764A patent/CA2914764C/en active Active
- 2014-06-09 EP EP14807179.8A patent/EP3003343B1/en active Active
- 2014-06-09 ES ES14807179T patent/ES2774217T3/es active Active
- 2014-06-09 AU AU2014274703A patent/AU2014274703B2/en not_active Ceased
- 2014-06-09 CN CN201480043222.XA patent/CN105431162B/zh active Active
- 2014-06-09 CN CN201911163740.6A patent/CN110981941A/zh active Pending
- 2014-06-09 WO PCT/US2014/041526 patent/WO2014197892A1/en not_active Ceased
- 2014-06-09 HU HUE14807179A patent/HUE047735T2/hu unknown
-
2015
- 2015-11-24 IL IL242760A patent/IL242760B/en active IP Right Grant
-
2017
- 2017-09-22 US US15/712,890 patent/US10774112B2/en active Active
-
2019
- 2019-01-18 JP JP2019006590A patent/JP6931011B2/ja active Active
-
2020
- 2020-08-10 US US16/989,416 patent/US11981754B2/en active Active
-
2024
- 2024-04-08 US US18/629,218 patent/US20240391957A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11981754B2 (en) | 2024-05-14 |
| US20160122390A1 (en) | 2016-05-05 |
| JP6470740B2 (ja) | 2019-02-13 |
| HK1222542A1 (zh) | 2017-07-07 |
| US20200361993A1 (en) | 2020-11-19 |
| JP2016521712A (ja) | 2016-07-25 |
| IL242760B (en) | 2021-03-25 |
| CN105431162A (zh) | 2016-03-23 |
| US20180134753A1 (en) | 2018-05-17 |
| WO2014197892A1 (en) | 2014-12-11 |
| EP3003343B1 (en) | 2019-10-23 |
| ES2774217T3 (es) | 2020-07-17 |
| CN105431162B (zh) | 2019-12-10 |
| EP3003343A4 (en) | 2016-11-30 |
| US10774112B2 (en) | 2020-09-15 |
| EP3643318A1 (en) | 2020-04-29 |
| US9802984B2 (en) | 2017-10-31 |
| CA2914764C (en) | 2021-10-26 |
| JP6931011B2 (ja) | 2021-09-01 |
| US20240391957A1 (en) | 2024-11-28 |
| DK3003343T3 (da) | 2020-02-03 |
| CN110981941A (zh) | 2020-04-10 |
| AU2014274703A1 (en) | 2015-12-10 |
| EP3003343A1 (en) | 2016-04-13 |
| JP2019089790A (ja) | 2019-06-13 |
| AU2014274703B2 (en) | 2019-07-04 |
| CA2914764A1 (en) | 2014-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE047735T2 (hu) | Egy biometrikus peptid és biológiailag lebomló szállító rendszer az angiogenesis- és lymphangiogenesis függõ betegségek kezelésében | |
| IL281354A (en) | Devices and methods for assisting a user of a drug delivery device | |
| EP3635591A4 (en) | SMART DRUG DELIVERY SYSTEMS AND PROCESSES | |
| IL274390A (en) | Dendrimer delivery system and methods for using it | |
| EP3402548C0 (en) | OCCLUSION RESOLUTION IN DRUG DELIVERY DEVICES, SYSTEMS, AND METHODS | |
| LT3240554T (lt) | Blautia stercosis ir wexlerae, skirtos naudoti uždegiminių ir autoimuninių ligų gydymui | |
| EP3167393A4 (en) | Medicine administering system including injection pen and companion device | |
| IL252418B (en) | Envenomation therapies and related pharmaceutical compositions, systems and kits | |
| PL3386531T3 (pl) | Zastosowanie wariantów peptydu natriuretycznego typu c w leczeniu choroby zwyrodnieniowej stawów | |
| LT3265140T (lt) | Transmukozinės ir transderminės pristatymo sistemos | |
| EP3802359A4 (en) | Smart medication dispensing system and method | |
| DK3432970T3 (da) | In vivo lægemiddelleveringsindretninger | |
| DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
| SMT202500469T1 (it) | Combinazione farmaceutica comprendente ponesimod e suo utilizzo nel trattamento della sclerosi multipla | |
| HUE040418T2 (hu) | Antimikrobiális peptid és felhasználásai | |
| EP3236992A4 (en) | Peptides and their use in the treatment of skin | |
| GB201619561D0 (en) | Medicament delivery device and system | |
| EP3570867A4 (en) | THERAPEUTIC PEPTIDES AND NEUROPROTECTORS | |
| GB201604213D0 (en) | Drug combination and its use in therapy | |
| EP3578566C0 (en) | BIOCIDAL PEPTIDE AND MEDICINAL PREPARATION ON THIS BASIS | |
| IL287985A (en) | A peptide derived from koc1 and a component containing it | |
| DK3378870T3 (da) | Nyt antimikrobielt peptid og anvendelse deraf | |
| EP3720422C0 (en) | LIPOSOMAL DRUG DELIVERY SYSTEM | |
| DK3472190T3 (da) | Fiibronectin-bindende peptider til anvendelse i tumor- og fibrosediagnosticering og -behandling | |
| DK3450448T3 (da) | Terapeutisk peptid til excitatorisk neurotoksicitets-relaterede skader |